Improving treatment options for opioid addiction
FY23. TO 10 - CTN CLINICAL COORDINATING CENTER - CTN-0144. PERIOD OF PERFORMANCE: SEPTEMBER 7, 2023, TO DECEMBER 31, 2027
This study is all about finding better ways to help people with opioid addiction by bringing together doctors, researchers, and patients to test new treatment options in real-life settings, so you can join in and help improve the support available for those facing this challenge.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | The Emmes Company, LLC NIH-funded |
| Lab location | 1 site (Rockville, United States) |
| Project ID | NIH-10938766 on NIH RePORTER |
What this research studies
This research focuses on enhancing the treatment of substance use disorders, particularly opioid addiction, by creating a collaborative network involving medical providers, researchers, and patients. It aims to develop, validate, and deliver new treatment options through rigorous clinical trials conducted in various community settings. Patients will have the opportunity to participate in trials that test behavioral and pharmacological interventions, ultimately aiming to improve the effectiveness of treatments available for those struggling with opioid dependence.
Who could benefit from this research
Good fit: Ideal candidates for participation are individuals struggling with opioid addiction or dependence who are seeking treatment.
Not a fit: Patients who are not dealing with opioid addiction or those who are not interested in participating in clinical trials may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and scientifically validated treatment options for individuals suffering from opioid addiction.
How similar studies have performed: Previous research within the National Drug Abuse Treatment Clinical Trials Network has shown success in developing effective treatments for substance use disorders.
Where this research is happening
Rockville, United States
- The Emmes Company, LLC — Rockville, United States (Active)
Researchers
- Principal investigator: Jelstrom, Eve — The Emmes Company, LLC
- Study coordinator: Jelstrom, Eve
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.